As of 2025-12-22, the Relative Valuation of Stoke Therapeutics Inc (STOK) is 21.99 USD. This relative valuation is based on P/E multiples. With the latest stock price at 31.96 USD, the upside of Stoke Therapeutics Inc based on Relative Valuation is -31.2%.
The range of the Relative Valuation is 15.93 - 28.31 USD.
| Range | Selected | |
| Trailing P/E multiples | 22.2x - 29.2x | 25.2x |
| Forward P/E multiples | 28.8x - 39.4x | 36.0x |
| Fair Price | 15.93 - 28.31 | 21.99 |
| Upside | -50.2% - -11.4% | -31.2% |
| Date | P/E |
| 2025-12-19 | 44.47 |
| 2025-12-18 | 44.43 |
| 2025-12-17 | 45.72 |
| 2025-12-16 | 46.77 |
| 2025-12-15 | 45.89 |
| 2025-12-12 | 45.07 |
| 2025-12-11 | 46.04 |
| 2025-12-10 | 47.52 |
| 2025-12-09 | 42.40 |
| 2025-12-08 | 45.92 |
| 2025-12-05 | 42.96 |
| 2025-12-04 | 43.21 |
| 2025-12-03 | 43.08 |
| 2025-12-02 | 41.48 |
| 2025-12-01 | 41.87 |
| 2025-11-28 | 43.01 |
| 2025-11-26 | 43.43 |
| 2025-11-25 | 41.49 |
| 2025-11-24 | 42.22 |
| 2025-11-21 | 40.83 |
| 2025-11-20 | 38.86 |
| 2025-11-19 | 39.63 |
| 2025-11-18 | 40.24 |
| 2025-11-17 | 37.50 |
| 2025-11-14 | 36.89 |
| 2025-11-13 | 36.28 |
| 2025-11-12 | 34.97 |
| 2025-11-11 | 34.94 |
| 2025-11-10 | 31.13 |
| 2025-11-07 | 31.81 |
| 2025-11-06 | 31.27 |
| 2025-11-05 | 31.75 |
| 2025-11-04 | 35.26 |
| 2025-11-03 | 36.32 |
| 2025-10-31 | 41.80 |
| 2025-10-30 | 44.11 |
| 2025-10-29 | 43.71 |
| 2025-10-28 | 44.01 |
| 2025-10-27 | 45.92 |
| 2025-10-24 | 44.92 |
| 2025-10-23 | 44.10 |
| 2025-10-22 | 45.25 |
| 2025-10-21 | 48.26 |
| 2025-10-20 | 48.22 |
| 2025-10-17 | 46.66 |
| 2025-10-16 | 47.55 |
| 2025-10-15 | 49.54 |
| 2025-10-14 | 48.62 |
| 2025-10-13 | 42.22 |
| 2025-10-10 | 42.01 |